Gene · 6548
Papers3,457
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,457
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Refined Ischemic Penumbra Imaging with Tissue pH and Diffusion Kurtosis Magnetic Resonance Imaging. | Transl Stroke Res | 2021 | 33159656 | PubTator, text mining | PubMed |
| Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations. | Diabetes Obes Metab | 2021 | 33155749 | PubTator, text mining | PubMed |
| PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy. | Eur J Pharmacol | 2021 | 33152335 | PubTator, text mining | PubMed |
| Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart. | Cardiovasc Res | 2021 | 33135077 | PubTator, text mining | PubMed |
| Effects of including sprints during prolonged cycling on hormonal and muscular responses and recovery in elite cyclists. | Scand J Med Sci Sports | 2021 | 33113253 | PubTator, text mining | PubMed |
| Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells. | Cardiovasc Drugs Ther | 2021 | 33048256 | PubTator, text mining | PubMed |
| The therapeutic importance of acid-base balance. | Biochem Pharmacol | 2021 | 33039418 | PubTator, text mining | PubMed |
| Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis. | JAMA Cardiol | 2021 | 33031522 | PubTator, text mining | PubMed |
| Phosphate as a Pathogen of Arteriosclerosis and Aging. | J Atheroscler Thromb | 2021 | 33028781 | PubTator, text mining | PubMed |
| Arsenic trioxide-increased MDCK cells proliferation requires activator protein 1-mediated increase of the sodium/proton exchanger 1 activity. | Biochim Biophys Acta Mol Basis Dis | 2021 | 32980460 | PubTator, text mining | PubMed |
| Characterization of intracellular buffering power in human induced pluripotent stem cells and the loss of pluripotency is delayed by acidic stimulation and increase of NHE1 activity. | J Cell Physiol | 2021 | 32841374 | PubTator, text mining | PubMed |
| A guide to plasma membrane solute carrier proteins. | FEBS J | 2021 | 32810346 | PubTator, text mining | PubMed |
| Duodenal mucosal secretory disturbances in functional dyspepsia. | Neurogastroenterol Motil | 2021 | 32776463 | PubTator, text mining | PubMed |
| Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients. | J Diabetes Investig | 2021 | 32563214 | PubTator, text mining | PubMed |
| Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis. | Prog Retin Eye Res | 2021 | 32438095 | PubTator, text mining | PubMed |
| Regional Differences in Human Biliary Tissues and Corresponding In Vitro-Derived Organoids. | Hepatology | 2021 | 32222998 | PubTator, text mining | PubMed |
| 23 Na-MRI as a Noninvasive Biomarker for Cancer Diagnosis and Prognosis. | J Magn Reson Imaging | 2021 | 32219933 | PubTator, text mining | PubMed |
| The impact of tumour pH on cancer progression: strategies for clinical intervention. | Explor Target Antitumor Ther | 2020 | 36046070 | PubTator, text mining | PubMed |
| Cardiac arrest: An interdisciplinary scoping review of the literature from 2019. | Resusc Plus | 2020 | 34223314 | PubTator, text mining | PubMed |
| Biophysical and epigenetic regulation of cancer stemness, invasiveness and immune action. | Curr Tissue Microenviron Rep | 2020 | 33817661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6548/papers?page=50